MIST Milestone Pharmaceuticals Inc.

Fundamentals / CIK 0001408443 / USD

Milestone Pharmaceuticals Inc. reported $162.7M in total assets and a net loss of $97.89M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MIST in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$0$0$0-$58.96MFY 2018 Net Income: -$23.18M2018FY 2019 Net Income: -$55.23M2019FY 2020 Net Income: -$49.97M2020FY 2021 Net Income: -$42.85M2021FY 2022 Net Income: -$58.39M2022FY 2023 Net Income: -$59.69M2023FY 2024 Net Income: -$41.52M2024FY 2025 Net Income: -$63.06M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $18.11M $14.36M $31.05M $39.83M $38.67M $34.49M $41.98M $16.85M
Operating Income -$62.14M -$42.10M -$61.10M -$59.64M -$43.07M -$50.71M -$57.88M -$23.82M
EBITDA -$62.03M -$42.00M -$61.01M -$59.55M -$42.98M -$50.61M -$57.84M -$23.81M
Interest Income $2.92M $4.16M $3.97M -- -- -- -- --
Interest Expense $3.84M $3.58M $2.55M -- -- -- -- --
Income Before Tax -$63.06M -$41.52M -$59.69M -$58.39M -$42.85M -$49.98M -$55.28M -$23.11M
Income Tax Expense -- -- -- -- -- -$17K -$56K $74K
Net Income -$63.06M -$41.52M -$59.69M -$58.39M -$42.85M -$49.97M -$55.23M -$23.18M
Basic EPS -$0.75 -$0.67 -$1.39 -$1.38 -$1.02 -$1.70 -$3.50 $72.63
Diluted EPS -$0.75 -$0.67 -$1.39 -$1.38 -$1.02 -$1.70 -$3.50 $72.63
Basic Shares Outstanding -- -- -- -- -- 29.3M 15.8M 319.2K
Diluted Shares Outstanding -- -- -- -- -- 29.3M 15.8M 319.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $2.96M $559K $238K -- $0 $0 $0 --
Cost of Revenue $325K $32K $14K -- $0 $0 $0 --
Gross Profit $2.64M $527K $224K -- $0 $0 $0 --
Research & Development $3.46M $3.51M $3.25M $5.52M $3.94M $3.67M $4.98M $3.94M
Selling, General & Admin $24.23M $22.65M -- -- $7.89M $8.86M -- --
Operating Income -$25.05M -$25.63M -$23.66M -$17.26M -$11.83M -$12.53M -$20.52M -$12.35M
EBITDA -$25.00M -$25.57M -$23.61M -$17.22M -$11.80M -$12.50M -$20.50M -$12.32M
Interest Income $1.44M $1.74M $1.73M $833K $874K $516K $697K $904K
Interest Expense $2.18M $4.72M $4.13M $985K $967K $951K $935K $919K
Net Income -$25.80M -$28.61M -$26.07M -$17.41M -$11.92M -$12.97M -$20.76M -$12.36M
Basic EPS -$0.18 -$0.21 -$0.20 -- -$0.12 -$0.20 -$0.31 --
Diluted EPS -$0.18 -$0.21 -$0.20 -- -$0.12 -$0.20 -$0.31 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $73.05M $25.31M $13.76M $7.64M $114.1M $72.31M $119.8M $85.95M
Short-Term Investments $32.91M $44.38M $52.24M $56.95M $0 $70.00M -- $29K
Cash & Short-Term Investments $106.0M $69.70M $66.00M $64.50M $114.1M $142.3M $119.8M $85.98M
Inventory $648K -- -- -- -- -- -- --
Total Current Assets $111.9M $73.93M $73.03M $71.80M $118.9M $148.7M $122.5M $88.05M
Property, Plant & Equipment, Net $511K $197K $277K $257K $215K $308K $405K $30K
Total Non-Current Assets $1.64M $1.57M $2.19M $2.68M $926K $1.29M $929K $30K
Total Assets $113.6M $75.50M $75.23M $74.48M $119.8M $150.0M $123.4M $88.08M
Accounts Payable $5.64M $1.93M $3.98M $2.26M $4.38M $4.64M $4.38M $2.60M
Other Current Liabilities $43K -- -- -- -- -- -- --
Total Current Liabilities $13.98M $8.13M $7.23M $6.14M $6.78M $6.16M $8.33M $4.53M
Long-Term Debt $57.19M $53.35M $49.77M -- -- -- $0 --
Other Non-Current Liabilities $83K -- -- -- -- -- -- --
Total Non-Current Liabilities $57.81M $54.23M $51.23M $2.00M $474K $696K $184K $0
Total Liabilities $71.79M $62.35M $58.45M $8.13M $7.25M $6.86M $8.51M $4.53M
Total Debt (incl. Leases) $58.38M $54.80M $51.77M $2.49M $687K $942K $514K --
Common Stock $352.6M $288.0M $260.5M $273.9M $251.9M $251.7M $226.2M $2.04M
Retained Earnings -$430.6M -$367.5M -$326.0M -$266.3M -$208.0M -$163.5M -$113.5M -$58.27M
Total Stockholders' Equity $41.77M $13.15M $16.77M $66.35M $112.6M $143.1M $114.9M $83.55M
Total Equity $41.77M $13.15M $16.77M $66.35M $112.6M $143.1M $114.9M -$55.21M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $144.5M $169.7M $71.32M $73.05M $46.69M $42.50M $45.09M $25.31M
Short-Term Investments $882K $881K $112.9M $32.91M $35.90M $918K $10.87M $44.38M
Cash & Short-Term Investments $145.4M $170.6M $184.2M $106.0M $82.60M $43.40M $56.00M $69.70M
Accounts Receivable, Net $3.93M $2.72M $1.60M -- -- -- -- --
Inventory $6.68M $4.72M $1.83M $648K -- -- -- --
Total Current Assets $161.6M $180.3M $192.3M $111.9M $86.67M $46.17M $60.48M $73.93M
Property, Plant & Equipment, Net $416K $469K $500K $511K $136K $159K $176K $197K
Total Non-Current Assets $1.09M $1.30M $1.48M $1.64M $1.08M $1.25M $1.41M $1.57M
Total Assets $162.7M $181.6M $193.7M $113.6M $87.75M $47.42M $61.88M $75.50M
Accounts Payable $9.23M $8.45M $10.02M $5.64M $3.18M $2.93M $2.38M $1.93M
Deferred Revenue (Current) $1.32M $1.03M $416K -- -- -- -- --
Other Current Liabilities $43K $43K $43K $43K -- -- -- --
Total Current Liabilities $25.78M $22.18M $20.94M $13.98M $10.52M $9.28M $12.96M $8.13M
Long-Term Debt $60.24M $59.21M $58.19M $57.19M $56.21M $55.24M $54.29M $53.35M
Other Non-Current Liabilities $51K $61K $72K $83K -- -- -- --
Total Non-Current Liabilities $143.1M $141.2M $136.7M $57.81M $56.73M $55.88M $55.05M $54.23M
Total Liabilities $168.9M $163.4M $157.7M $71.79M $67.25M $65.16M $68.01M $62.35M
Total Debt (incl. Leases) $60.94M $60.07M $59.22M $58.38M $57.21M $56.39M $55.59M $54.80M
Common Stock $385.0M $385.0M $373.7M $352.6M $311.8M $288.3M $288.2M $288.0M
Retained Earnings -$511.1M -$485.3M -$456.7M -$430.6M -$413.2M -$401.3M -$388.3M -$367.5M
Total Stockholders' Equity -$6.22M $18.22M $36.05M $41.77M $20.50M -$17.75M -$6.12M $13.15M
Total Equity -$6.22M $18.22M $36.05M $41.77M $20.50M -$17.75M -$6.12M $13.15M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$63.06M -$41.52M -$59.69M -$58.39M -$42.85M -$49.97M -$55.23M -$23.18M
Depreciation & Amortization $114K $105K $92K $89K $93K $97K $38K $10K
Stock-Based Compensation $7.46M $5.78M $9.53M $9.05M $7.28M $4.95M $1.19M $633K
Change in Inventory -$648K -- -- -- -- -- -- --
Operating Cash Flow -$49.04M -$28.85M -$46.42M -$52.47M -$33.22M -$50.73M -$51.15M -$21.05M
Capital Expenditure -$302K -$33K -$112K -$272K -- -- -$413K -$5.0K
Free Cash Flow -$49.34M -$28.88M -$46.54M -$52.74M -- -- -$51.56M -$21.05M
Investing Cash Flow $11.25M $8.28M $4.76M -$57.12M $70.00M -$70.00M -$384K $16.00M
Common Stock Issued $37.59M $27.26M -- $2.63M -- $24.92M -- --
Financing Cash Flow $85.53M $32.12M $47.79M $3.09M $5.05M $73.22M $85.41M $80.11M
Net Change in Cash $47.73M $11.55M $6.12M -$106.5M $41.83M -$47.51M $33.87M $75.07M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$25.80M -$28.61M -$26.07M -$17.41M -$11.92M -$12.97M -$20.76M -$12.36M
Depreciation & Amortization $57K $57K $56K $34K $25K $28K $27K $26K
Stock-Based Compensation $1.36M $1.34M $1.28M $3.55M $1.25M $1.31M $1.35M $1.47M
Change in Receivables -$1.21M -$1.11M -$1.60M -- -- -- -- --
Change in Inventory -$1.95M -$2.90M -$1.18M -- -- -- -- --
Change in Payables $781K -$1.57M $4.38M -- $255K $544K $452K --
Operating Cash Flow -$25.24M -$22.71M -$16.05M -$12.78M -$9.75M -$12.57M -$13.95M -$6.84M
Capital Expenditure -$4.0K -$26K -$45K -$283K -$2.0K -$11K -$6.0K --
Free Cash Flow -$25.25M -$22.74M -$16.10M -$13.06M -$9.75M -$12.58M -$13.96M --
Investing Cash Flow -$5.0K $112.0M -$80.03M $2.70M -$34.98M $9.94M $33.58M $19.33M
Common Stock Issued $0 $0 $10.89M -- -- -- -- $0
Financing Cash Flow -$9.0K $9.13M $94.35M $36.43M $48.92M $36K $140K $24K
Net Change in Cash -$25.26M $98.41M -$1.73M $26.36M $4.19M -$2.59M $19.77M $12.52M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -151.0% -315.8% -355.9% -88.0% -38.1% -34.9% -48.1% -27.8%
Return on Assets (ROA) -55.5% -55.0% -79.3% -78.4% -35.8% -33.3% -44.7% -26.3%
Current Ratio 8.01x 9.10x 10.11x 11.70x 17.55x 24.14x 14.71x 19.42x
Quick Ratio 7.96x 8.58x 9.13x 10.51x 16.84x 23.10x 14.39x 18.97x
Debt to Equity 1.40x 4.17x 3.09x 0.04x 0.01x 0.01x 0.00x --
EPS Growth (YoY) -- -- -- -- -- -- -104.8% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -461.1% -189.6% -151.0% -283.0% -- -- -315.8%
Return on Assets (ROA) -60.2% -46.3% -35.3% -55.5% -66.1% -117.1% -83.9% -55.0%
Current Ratio 6.27x 8.13x 9.18x 8.01x 8.24x 4.97x 4.67x 9.10x
Quick Ratio 6.01x 7.92x 9.09x 7.96x 7.85x 4.68x 4.32x 8.58x
Debt to Equity -- 3.30x 1.64x 1.40x 2.79x -- -- 4.17x
Source: SEC EDGAR CompanyFacts (CIK 0001408443) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:50 UTC · Open in terminal